Related stories
Merck Beats Third-Quarter Forecasts on Keytruda and Gardasil
Merck's third-quarter results exceeded forecasts, supported by strong performance from Keytruda and Gardasil.
M impact | EARNINGS | Oct 29, 2026, 12:26 PM UTC
Merck Beats Third-Quarter Expectations as Keytruda and Gardasil Outperform
Merck exceeded third-quarter expectations, with Keytruda and Gardasil performing better than expected.
M impact | EARNINGS | Oct 29, 2026, 12:26 PM UTC
Ameriprise Reports Total Net Revenues of $5,117 Million
L impact | EARNINGS | Oct 29, 2026, 12:25 PM UTC
Enterprise Products rises on core profit beat
M impact | EARNINGS | Oct 29, 2026, 12:25 PM UTC
BorgWarner Q3 Sales Fall 2.9%; Adjusted EPS Rises 12.1%
BorgWarner reported third-quarter 2026 net sales of $3.487 billion, down 2.9% year over year, and diluted EPS of $1.08. Adjusted diluted EPS rose 12.1% to $1.39, and the company ra
M impact | EARNINGS | Oct 29, 2026, 12:25 PM UTC
WEC Energy beats Q3 EPS consensus by $0.21, guides FY26 above consensus
WEC Energy Group reported Q3 EPS of $1.18, $0.21 above the FactSet consensus of $0.97. Revenue was in line, and FY26 EPS guidance is above consensus.
M impact | EARNINGS | Oct 29, 2026, 12:25 PM UTC